These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Design, synthesis, and evaluation of metabolism-based analogues of haloperidol incapable of forming MPP+-like species. Lyles-Eggleston M; Altundas R; Xia J; Sikazwe DM; Fan P; Yang Q; Li S; Zhang W; Zhu X; Schmidt AW; Vanase-Frawley M; Shrihkande A; Villalobos A; Borne RF; Ablordeppey SY J Med Chem; 2004 Jan; 47(3):497-508. PubMed ID: 14736232 [TBL] [Abstract][Full Text] [Related]
6. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors. Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789 [TBL] [Abstract][Full Text] [Related]
7. Are dopamine D2 receptors out of control in psychosis? Seeman P Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():146-52. PubMed ID: 23880595 [TBL] [Abstract][Full Text] [Related]
8. Haloperidol: towards further understanding of the structural contributions of its pharmacophoric elements at D2-like receptors. Sikazwe DM; Li S; Mardenborough L; Cody V; Roth BL; Ablordeppey SY Bioorg Med Chem Lett; 2004 Dec; 14(23):5739-42. PubMed ID: 15501032 [TBL] [Abstract][Full Text] [Related]
9. N-(1-Benzylpyrrolidin-3-yl)arylbenzamides as potent and selective human dopamine D4 antagonists. Egle I; Barriault N; Bordeleau M; Drage J; Dube L; Peragine J; Mazzocco L; Arora J; Jarvie K; Tehim A Bioorg Med Chem Lett; 2004 Oct; 14(19):4847-50. PubMed ID: 15341937 [TBL] [Abstract][Full Text] [Related]
10. New series of morpholine and 1,4-oxazepane derivatives as dopamine D4 receptor ligands: synthesis and 3D-QSAR model. Audouze K; Nielsen EØ; Peters D J Med Chem; 2004 Jun; 47(12):3089-104. PubMed ID: 15163190 [TBL] [Abstract][Full Text] [Related]
11. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors. Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712 [TBL] [Abstract][Full Text] [Related]
12. D4 receptors and their antagonists. Hadley MS Med Res Rev; 1996 Nov; 16(6):507-26. PubMed ID: 8923442 [No Abstract] [Full Text] [Related]
13. Design and synthesis of 2-naphthoate esters as selective dopamine D4 antagonists. Boyfield I; Brown TH; Coldwell MC; Cooper DG; Hadley MS; Hagan JJ; Healy MA; Johns A; King RJ; Middlemiss DN; Nash DJ; Riley GJ; Scott EE; Smith SA; Stemp G J Med Chem; 1996 May; 39(10):1946-8. PubMed ID: 8642552 [No Abstract] [Full Text] [Related]
14. A solution-phase combinatorial synthesis of selective dopamine D4 ligands. Williams JP; Lavrador K Comb Chem High Throughput Screen; 2000 Feb; 3(1):43-50. PubMed ID: 10702613 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs. Sukalović V; Andrić D; Roglić G; Kostić-Rajacić S; Schrattenholz A; Soskić V Eur J Med Chem; 2005 May; 40(5):481-93. PubMed ID: 15893022 [TBL] [Abstract][Full Text] [Related]